Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDAH1 | O94760 | 1/20 | 0.39 |
| ▸ | NSD2 | O96028 | 1/20 | 0.39 |
| ▸ | G6PD | P11413 | 1/20 | 0.39 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.39 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.39 |
| ▸ | MGLL | Q99685 | 7/20 | 0.38 |
| ▸ | GSK3A | P49840 | 3/20 | 0.38 |
| ▸ | GSK3B | P49841 | 3/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 5/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 5/20 | 0.37 |
| ▸ | FAAH | O00519 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 4/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.33 |
| ▸ | BLM | P54132 | 2/20 | 0.33 |
| ▸ | PKM | P14618 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | ATM | Q13315 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | TLR9 | Q9NR96 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL711961 | 0.78 | NSD2 (0.41) | DDAH1NSD2G6PDKEAP1NFE2L2 | |
| SCHEMBL2801370 | 0.73 | LMNA (0.43) | DDAH1NSD2G6PDKEAP1NFE2L2 | |
| SCHEMBL11880206 | 0.73 | MGLL (0.36) | DDAH1NSD2G6PDKEAP1NFE2L2 | |
| SCHEMBL28570540 | 0.73 | P2RX4 (0.37) | DDAH1NSD2G6PDKEAP1NFE2L2 | |
| SCHEMBL720720 | 0.73 | MGLL (0.43) | DDAH1NSD2G6PDKEAP1NFE2L2 | |
| SCHEMBL7110683 | 0.73 | DDAH1 (0.34) | DDAH1NSD2G6PDKEAP1NFE2L2 | |
| SCHEMBL1321593 | 0.69 | P2RX4 (0.57) | MGLLGSK3AGSK3BALDH1A1HSP90AA1 | |
| SCHEMBL4761585 | 0.69 | MGLL (0.35) | DDAH1NSD2G6PDKEAP1NFE2L2 | |
| SCHEMBL284850 | 0.69 | MGLL (0.33) | DDAH1NSD2G6PDKEAP1NFE2L2 | |
| SCHEMBL10586150 | 0.69 | MGLL (0.38) | DDAH1NSD2G6PDKEAP1NFE2L2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 337 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117304811-A | High-functionality vegetable oil-based UV (ultraviolet) light-cured resin as well as preparation method and application thereof | 佛山科学技术学院 | 2023-12-29 | — | — | CN | claimed |
| CN-117165366-A | Universal UV light-cured modified vegetable oil resin and synthetic method and application thereof | 佛山科学技术学院 | 2023-12-05 | — | — | CN | claimed |
| EP-2244718-B1 | PEPTIDES HAVING BINDING AFFINITY TO AN ANTIBODY WHICH RECOGNIZES AN EPITOPE ON AN 1 LOOP 2 OR 2 LOOP 1 OF AN ADRENORECEPTOR | MDC MAX-DELBRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN BERLIN - BUCH (DE) | 2017-06-07 | — | — | EP | claimed |
| US-20130302292-A1 | PEPTIDES HAVING BINDING AFFINITY TO AN ANTIBODY WHICH RECOGNIZES AN EPITOPE ON AN ALPHA1 LOOP 2 OR BETA2 LOOP 1 OF AN ADRENORECEPTOR | FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH (DE) | 2013-11-14 | — | — | US | claimed |
| US-8058019-B2 | Method for assaying antibodies in body fluids by immune reaction with glycoprotein 2 (GP2) from zymogenic granules of the pancreas for the differential diagnosis of inflammatory intestinal diseases and chronic pancreatitis | GA GENERIC ASSAYS GMBH (DE) | 2011-11-15 | — | — | US | claimed |
| US-20110104226-A1 | PEPTIDES HAVING BINDING AFFINITY TO AN ANTIBODY WHICH RECOGNIZES AN EPITOPE ON AN A1 LOOP 2 OR BETA2 LOOP 1 OF AN ADRENORECEPTOR | FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH (DE) | 2011-05-05 | — | — | US | claimed |
| EP-2244718-A2 | PEPTIDES HAVING BINDING AFFINITY TO AN ANTIBODY WHICH RECOGNIZES AN EPITOPE ON AN 1 LOOP 2 OR 2 LOOP 1 OF AN ADRENORECEPTOR | Mdc Max-Delbrück-Centrum Für Molekulare Medizin Berlin - Buch (DE) | 2010-11-03 | — | — | EP | claimed |
| US-20100266686-A1 | ANTI-AMYLOID ANTIBODIES AND THEIR USE IN DIAGNOSIS AND THERAPY OF AMYLOID DISEASES | HANS-KNOELL-INSTITUT FUER NATURSTOFFFORSCHUNG (DE) | 2010-10-21 | — | — | US | claimed |
| US-20100184662-A1 | METHOD FOR ASSAYING ANTIBODIES IN BODY FLUIDS BY IMMUNE REACTION WITH GLYCOPROTEIN 2 (GP2) FROM ZYMOGENIC GRANULES OF THE PANCREAS FOR THE DIFFERENTIAL DIAGNOSIS OF INFLAMMATORY INTESTINAL DISEASES AND CHRONIC PANCREATITIS | GA GENERIC ASSAYS GMBH (DE) | 2010-07-22 | — | — | US | claimed |
| WO-2010069570-A2 | PEPTIDES AGAINST AUTOANTIBODIES ASSOCIATED WITH CRPS AND USE OF THESE PEPTIDES | Max-Delbrück-Centrum für Molekulare Medizin (DE) | 2010-06-24 | — | — | WO | claimed |
| US-7141691-B2 | Protein-bound derivatives of platinum complexes containing cyclobutane1, 1-dicarboxyllate ligands | KTB TUMORFORSCHUNGS GMBH (DE) | 2006-11-28 | — | — | US | claimed |
| EP-1214350-B1 | PEPTIDES FOR COMBATING THE AUTOANTIBODIES THAT ARE RESPONSIBLE FOR DILATATIVE CARDIOMYOPATHY (DCM) | FRESENIUS MEDICAL CARE AFFINA (DE) | 2006-09-06 | — | — | EP | claimed |
| US-20060089341-A1 | Protein-bound derivatives of platinum complexes containing cyclobutane1,1-dicarboxyllate ligands | KTB TUMORFORSCHUNGS GMBH (DE) | 2006-04-27 | — | — | US | claimed |
| US-20060047140-A1 | Process for producing polymerizable polybranched polyester | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2006-03-02 | — | — | US | claimed |
| EP-1591451-A1 | PEPTIDE CONJUGATE | Keio University (JP) | 2005-11-02 | — | — | EP | claimed |
| EP-1582548-A1 | PROCESS FOR PRODUCING POLYMERIZABLE POLYBRANCHED POLYESTER | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2005-10-05 | — | — | EP | claimed |
| US-20040087765-A1 | Peptides, the production and use thereof for binding immunoglobulins | FRESENIUS MEDICAL CARE AFFINA GMBH (DE) | 2004-05-06 | — | — | US | claimed |
| US-20040023048-A1 | Enhanced bonding layers on native oxide surfaces | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2004-02-05 | — | — | US | claimed |
| EP-0336856-B1 | WITH MALEIMIDE GROUPS FUNCTIONALIZED AROMATIC POLYAMIDEIMIDES, PROCESS FOR THEIR PREPARATION AND THEIR USE FOR PREPARING CROSS-LINKED POLYMERS | CIBA-GEIGY AG (CH) | 1993-03-03 | — | — | EP | claimed |
| US-4131707-A | POLYMALEIMIDES | CIBA-GEIGY CORPORATION (US) | 1978-12-26 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040087765-A1 | Peptides, the production and use thereof for binding immunoglobulins | IGSF11, FCGRT, F13A1 | DDAH1 2002/4885NSD2 4779/4885G6PD 4162/4885 |
| US-20060047140-A1 | Process for producing polymerizable polybranched polyester | ACSL4, ACSL1, HACL2 | DDAH1 178/4885NSD2 3094/4885G6PD 2216/4885 |
| US-20060089341-A1 | Protein-bound derivatives of platinum complexes containing cyclobutane1,1-dicarboxyllate ligands | DDB1, DCLRE1A, PDCD1LG2 | DDAH1 712/4885NSD2 4262/4885G6PD 2604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.